pGV15 (CK2alpha K68M) Citations (3)

Originally described in: Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: strategies to identify CK2 substrates and manipulate its activity in mammalian cells.
Turowec JP, Duncan JS, French AC, Gyenis L, St Denis NA, Vilk G, Litchfield DW. Methods Enzymol. 2010;484:471-93. PubMed Journal

---

Articles Citing pGV15 (CK2alpha K68M)

Articles
sNASP inhibits TLR signaling to regulate immune response in sepsis. Yang FM, Zuo Y, Zhou W, Xia C, Hahm B, Sullivan M, Cheng J, Chang HM, Yeh ET. J Clin Invest. 2018 Jun 1;128(6):2459-2472. doi: 10.1172/JCI95720. Epub 2018 May 7. PubMed
Co-targeting CK2alpha and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway. Xu WF, Ma YC, Ma HS, Shi L, Mu H, Ou WB, Peng J, Li TT, Qin T, Zhou HM, Fu XQ, Li XH. Cell Cycle. 2019 Dec;18(24):3472-3490. doi: 10.1080/15384101.2019.1689474. Epub 2019 Nov 12. PubMed
Casein kinase 2 phosphorylates and induces the SALL2 tumor suppressor degradation in colon cancer cells. Hermosilla VE, Gyenis L, Rabalski AJ, Armijo ME, Sepulveda P, Duprat F, Benitez-Riquelme D, Fuentes-Villalobos F, Quiroz A, Hepp MI, Farkas C, Mastel M, Gonzalez-Chavarria I, Jackstadt R, Litchfield DW, Castro AF, Pincheira R. Cell Death Dis. 2024 Mar 16;15(3):223. doi: 10.1038/s41419-024-06591-z. PubMed

If you have published an article using this material, please email us at to have your article added to this page.